Patent directory · USPTO A61K / A61P
Patents matching “therapy”
782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12318362
Methods of providing solriamfetol therapy to subjects with impaired renal function
granted -
US 12318401
Injectable shear-thinning hydrogel containing therapeutic agent for enhanced tumor therapy
granted -
US 12319738
Anti-FGFR2 antibodies in combination with chemotherapy agents in gastric cancer
granted -
US 12318413
Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome
granted -
US 12311030
Antibody-sting agonist conjugates and their use in immunotherapy
granted -
US 12310996
Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome
granted -
US 12303551
Cellular immunotherapy compositions and uses thereof
granted -
US 12297447
Gene therapy for juvenile Batten disease
granted -
US 12297509
Biomarkers for predicting tumor response to and toxicity of immunotherapy
granted -
US 12285496
Gene therapy for haploinsufficiency
granted -
US 12280140
Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
granted -
US 12275955
Combining iPSC derived effector cell types for immunotherapy use
granted -
US 12258401
Anti-CD47 combination therapy
granted -
US 12247206
Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer
granted -
US 12246064
Method of treating Crohn's disease by administering a triple combination therapy of anti-integrin antibody, adalimumab and methotrexate
granted -
US 12239712
Combination therapy for the treatment of liver disease
granted -
US 12233103
Indoleamine 2,3-dioxygenase based immunotherapy
granted -
US 12230364
Immunotherapy methods for patients whose tumors carry a high passenger gene mutation burden
granted -
US 12230378
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted -
US 12230379
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted -
US 12228582
Method and apparatus for testing near infrared-photoimmunotherapy treatment
granted -
US 12226434
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 12220389
Combination therapy for the treatment of tinnitus and other medical conditions
granted -
US 12220420
Combination therapy for cancer treatment
granted